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An international review of the patterns and
determinants of health service utilisation by adult
cancer survivors
Charlene Treanor1* and Michael Donnelly1,2
Abstract
Background: There is a need to review factors related to health service utilisation by the increasing number of
cancer survivors in order to inform care planning and the organisation and delivery of services.
Methods: Studies were identified via systematic searches of Medline, PsycINFO, CINAHL, Social Science Citation
Index and the SEER-MEDICARE library. Methodological quality was assessed using STROBE; and the Andersen
Behavioural Model was used as a framework to structure, organise and analyse the results of the review.
Results: Younger, white cancer survivors were most likely to receive follow-up screening, preventive care, visit their
physician, utilise professional mental health services and least likely to be hospitalised. Utilisation rates of other
health professionals such as physiotherapists were low. Only studies of health service use conducted in the USA
investigated the role of type of health insurance and ethnicity. There appeared to be disparate service use among
US samples in terms of ethnicity and socio-demographic status, regardless of type of health insurance provision
s- this may be explained by underlying differences in health-seeking behaviours. Overall, use of follow-up care
appeared to be lower than expected and barriers existed for particular groups of cancer survivors.
Conclusions: Studies focussed on the use of a specific type of service rather than adopting a whole-system
approach and future health services research should address this shortcoming. Overall, there is a need to improve
access to care for all cancer survivors. Studies were predominantly US-based focussing mainly on breast or
colorectal cancer. Thus, the generalisability of findings to other health-care systems and cancer sites is unclear. The
Andersen Behavioural Model provided an appropriate framework for studying and understanding health service use
among cancer survivors. The active involvement of physicians and use of personalised care plans are required in
order to ensure that post-treatment needs and recommendations for care are met.
Keywords: Cancer survivor, Health service utilisation, Systematic review, Andersen Behavioural Model
Background
The number of cancer survivors (CSs) is increasing
steadily due to several factors including improved med-
ical treatment and an aging population [1]. However,
there are relatively few studies about health service use
by individuals with this chronic condition. The few stud-
ies that have been conducted in this field provide mixed
results about the nature and extent to which CSs have
poorer health and a greater need for services than
primary care patients and other chronic disease groups
[2,3]. There is a need to investigate health service utilisa-
tion in order to understand access to services, identify
any service gaps and to improve organisational efficiency
and cost-effectiveness [4]. The nature and type of ser-
vices required by the CS population including effective
and efficient ways in which to organise, deliver and fa-
cilitate services is relatively unexamined. The purpose of
this paper is to present the results of a systematic review
of the literature related to the patterns and determinants
of the use of preventive health care services, hospital
care and primary care by cancer survivors.* Correspondence: ctreanor05@qub.ac.uk1Cancer Epidemiology & Health Services Research Group, Centre for Public
Health, Queen’s University Belfast, Belfast, UK
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Methods
MEDLINE, CINAHL, PsycINFO, Social Science Citation
Index and the SEER-MEDICARE online library of publi-
cations were searched from 1950 to August 2011. The
search terms revolved around the key concepts: cancer
survivors and health service utilisation (see Figure 1).
The methodology adhered to guidelines by the Centre
for Review and Dissemination [5]. Independent study se-
lection was undertaken by two reviewers who achieved
98 % agreement. Data were extracted using a pre-
specified pro-forma.
Papers published in peer-review journals were
included if participants were diagnosed with cancer in
adulthood; had completed active treatment with curative
intent and were not in receipt of palliative care. Non-
melanoma skin CSs were excluded as both treatment
and survival differ from other cancer sites [6]. The re-
view included studies of key formal service components
including primary care, hospital services, social services,
mental health services (and their costs). Studies of
eHealth systems, lay-led supportive services, dentistry
and complementary and alternative medicine were
excluded. Many CSs use these other types of services,
particularly complementary and alternative therapies in
order to manage the long-term morbidity associated
with cancer. However, these service types were excluded
from the review due to resource limitations and each
service type would warrant a separate review.
The STrengthening the Reporting of OBservational
studies in Epidemiology (STROBE) checklist was supple-
mented with a survey appraisal checklist in order to ap-
praise the methodological quality of the full range of
study types [7,8].
The Andersen Behavioural Model provided the theor-
etical and organisational framework for the review and
synthesis of studies. Service use by CSs was explained in
terms of three main components: characteristics which
predispose (e.g. age, sex and health beliefs) an individual to
use health care; enabling characteristics (e.g. resources)
that facilitate access to health care; and need in the form
of an illness or symptoms that require care (e.g. follow-up
screening to detect cancer recurrence or metastases). This
model was used as the organisational framework because
it was developed as an explanatory framework explicitly
for health service utilisation; it has been applied across
various types of health services and health care systems
and there is a large associated international literature on
its performance. It encompasses individual characteristics
and takes into consideration the context in which health
care occurs.
Results
Study characteristics
A total of 38 studies were included in the review (see
Figure 2); studies took place in the USA (27), UK (3),
Netherlands (3), Canada (3), France (1) and Denmark
(1). Breast CSs were the population of interest in the
majority of studies (18); other studies comprised colo-
rectal CSs (11), uterine CSs (1) or survivors from a num-
ber of cancer sites (7). See Tables 1 and 2 for study
characteristics. The country of study origin is stated in
the results below unless studies were conducted in the
USA. Studies focussed on primary care (26), post-active
treatment cancer surveillance (15), preventive care, e.g. in-
fluenza vaccination, (8), mental health service use, e.g.
psychologists, (3) and hospital care, including inpatient
and outpatient services (2). Use of social services was not
a primary focus of any of the identified papers. The studies
investigated the prediction of service utilisation but not
the nature and extent of service integration and coordin-
ation. Quality appraisal scores ranged from 11 to 20,
(mean= 17), indicating that the majority of studies
(n= 25) were very good quality. No study exclusions were
made based on quality.
Primary care
Predisposing characteristics
The US health-care system permits individuals to choose
to an extent which health care provider provides their
care in relation to their insurance plan restrictions or ab-
sence of an insurance plan. Specialists are included in
this section on primary care as data indicated that there
is a limited set of services used by patients in the US
health care system that may be provided by a specialist
such as an oncologist or by a primary care physician.
There was a consistent association between contact with
primary care and predisposing characteristics such as
age, ethnicity, gender and time since diagnosis. Contact
with services for cancer-related problems and all symp-
toms and illnesses are included within the results. Stud-
ies were inconsistent regarding whether younger or
older CSs were more likely to visit an oncologist or a
primary care physician. Younger colorectal CSs were
Figure 1 Full search strategy.
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Figure 2 Search and screening results.
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more likely to visit both a primary care physician and an
oncologist, whereas older colorectal CSs were more
likely to visit only a primary care physician [9,10]. More-
over, younger breast CSs from the US were more likely
to visit an oncologist [11], whereas older breast CSs
from Denmark were most likely to visit their primary
care physician [12]. Differences in the pattern of primary
care utilisation by ethnicity were found across cancer
sites. Black colorectal CSs were more likely to receive care
from physicians other than a primary care physician,
whereas, white colorectal CSs were more likely to receive
care from a primary care physician [10]. Furthermore,
white breast CSs were more likely to utilise health services
compared to black CSs [13]. Compared to male colorectal
CSs, female colorectal CSs were more likely to receive
care from a primary care physician and an oncologist than
either one of these physicians only [9]. Only one study
(conducted in the Netherlands) addressed time since diag-
nosis and the use of primary care services. Dutch endo-
metrial CSs diagnosed between 10 and 15 years previously
were less likely to visit a primary care physician than CSs
diagnosed within 10 years or very long-term survivors at
least 15 years post-diagnosis [14].
Enabling characteristics
Area of residence, participation in an intervention, primary
care physician-orientated follow-up and marital status (as a
proxy for social support) acted as significant enablers for
primary care service use. French colorectal CSs from the
Saône and Loire regions were more likely to have made
regular contact with a primary care physician than CSs
from other French regions [15]. One UK study demon-
strated that the orientation of follow-up cancer care was
important for health service use. CSs who received
hospital-oriented follow-up had lower health-care utilisa-
tion rates compared to CSs whose follow-up care was
oriented by their primary care physician [16]. A small
proportion of Canadian breast cancer survivors whose
follow-up care was provided by a primary care provider
made visits to an oncologist over a 12 month period [17].
A reduction in health service use was observed for breast
CSs who participated in a psychotherapy-based inter-
vention to reduce stress [18]. One study from the Nether-
lands found that a lack of social support (i.e. CSs who were
single or divorced) led to less use of health services com-
pared to CSs who were married [14].
Need characteristics
A number of studies found that co-morbidities were
associated with visits to primary care. Breast CSs with a
co-morbidity, or self-reported poor functioning or high
depressive mood had greater service utilisation and
health-care costs than breast CSs without a co-morbid-
ity, or who reported better functioning or had low scores
low depressive mood [13]. Similarly in the Netherlands
health service utilisation rates were two times greater for
cancer survivors with a co-morbidity compared to CSs
without a co-morbidity [14]. It is not clear from the
findings whether CSs were more or less likely to utilise
primary care services compared to a non-cancer control
population. Compared to individuals without cancer, US
and UK colorectal CSs, UK prostate CSs and Dutch
endometrial survivors [14,19,20], were significantly more
likely to visit their primary care physician. However,
Dutch CSs and Danish breast CSs had similar primary
care physician use as non-cancer controls [12,21,22]. In
terms of the level of contact made with primary care
patterns of utilisation changed over time. Contact with
oncologists largely decreased over time, whereas visits to
a primary care physician largely increased over time. An-
nual visits to primary care physicians and oncologists
were made by 51 % and 27 % of breast CSs respectively
[11]. Within the first year of survivorship there was a
high health service utilisation rate for breast CSs; an
average of 14 visits per individual was made to a medical
provider including a primary care physician or an on-
cologist [13]. Approximately 50 % of CSs visited an on-
cologist alongside other physicians, whereas 8 % of CSs
made visits to only an oncologist [19]. One cross-
sectional study reported that 52 % of breast CSs made
visits to both an oncologist and a primary care physician,
whereas 41 % visited a primary care physician only and
4 % visited an oncologist only [23]. The level of contact
made to both primary care physicians and oncologists
decreased over a three year period, from 70-42 % and
30-17 %, respectively. One longitudinal study found that
in the first year of follow-up, the majority of breast CSs
made visits to both physicians; over time the number of
visits made to a primary care physician decreased and
the number of visits made to an oncologist increased
[24]. In contrast, further studies reported an increase in
the number of visits to a primary care physician and a
decrease of visits to an oncologist and other physicians
over time for colorectal and breast CSs respectively
[9,10,13,20,25-27].
Follow-up cancer surveillance
Predisposing characteristics
Follow-up cancer surveillance includes any test which is
used to screen for recurrence or metastases of the pri-
mary cancer. Each study which addressed the predispos-
ing characteristics associated with CSs who utilised
follow-up cancer surveillance procedures was conducted
in the USA. Predisposing characteristics found to be sig-
nificantly related to follow-up cancer surveillance were
age, ethnicity, gender and health beliefs. Older age was
associated with receipt of less follow-up cancer surveillance
procedures. Compared to their younger counterparts, older
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Table 1 Study Characteristics
Author Year Country Sample characteristics Analysis Variables/Measures Outcome Quality appraisal
Andersen
and Urban [36]
1998 USA Breast cancer survivors n = 485
50–80 years old 3-20+ years
post-diagnosis
Multiple logistic regression Receipt of mammogram, usual source
of care,1 recommendation by physician
for mammogram and insurance coverage
Receipt of mammogram Average
Andrykowski
and Burris [45]
2010 USA SEER database Breast cancer
survivors n = 42 Colorectal
cancer survivors n = 33
Hematological cancer survivors
n = 38 1–5 years post-diagnosis
Aged 25–75 years old
Multiple regression Socio-demographics, cancer characteristics,
mental health resource questionnaire
Use of formal and informal
mental health services
Very good
Boehmer et al. [34] 2010 USA Colorectal cancer survivors Aged
22–92 years old n = 253
Cox proportional hazard
models
Colonoscopies, sigmoidoscopy,
cancer type, stage, co-morbidities,
outpatient visits, socio-demographics
Receipt of colorectal
surveillance procedures
Very good
Cooper et al. [29] 2000 USA SEER-MEDICARE database
Colorectal cancer survivors
Localised disease Surgically
treated >65 years old
n = 5, 716
Chi-square test Socio-demographics, inpatient
claims, outpatient claims, use
of endoscopic procedures
(colonoscopy, polypectomy
or biopsy)
Receipt of colorectal
surveillance procedures
Very good
Cooper
and Payes [28]
2006 USA SEER-MEDICARE database
Colorectal cancer survivors
>65 years old n = 62, 882
survived 1 year follow-up n= 35,
784 survived 3 year follow-up
Logistic regression Medicare claims2 for colonoscopy,
sigmoidoscopy or barium
enema, co-morbidities
Use of surveillance
procedures for colorectal
cancer within 3 years of
diagnosis
Very good
Cooper, Kou
and Reynolds [31]
2008 USA SEER database Colorectal cancer
survivors >65 years old n = 9, 426
Multivariate regression Number of physician visits, receipt of
carcino-embryonic antigen blood test
(CEA),3 colonoscopy, CT and PET
scans
Adherence to guidelines
for cancer follow-up
Good
Doubeni et al. [27] 2006 USA Breast cancer survivors n = 797
at baseline (end of treatment)
n = 262 after 5 yrs >55 years
old 4 geographically diverse
Health Maintenance Organisations
(HMOs).4
Generalised estimated
equations (GEE)
Receipt of mammograms. age, date
and stage at/of diagnosis, treatment.
co-morbidities. visits to primary care
provider (primary care physician)
and outpatient visits
Receipt of yearly
mammogram and visits to
physicians
Very good
Earle et al. [23] 2003 USA SEER database Breast cancer
survivors > 65 years old, n = 5,965
Controls n = 6,062
Multivariate regression Frequency of visits to primary
care physician, oncologists,
other and teaching hospitals,
receipt of flu vaccine, lipid test,
cervical exam, colon exam,
bone densitometry and
diabetes test
Visits to physicians
and receipt of preventive
medicine
Very good
Earle and
Neville [19]
2004 USA SEER database Colorectal cancer
survivors > 65 years old
n = 14,884
Logistic regression Co-morbidities, socio-demographics,
receipt of flu vaccine, lipid testing, bone
densitometry and cervical screening
Visits to physicians
and receipt of preventive
medicine
Very good
Earle, Neville
and Fletcher [43]
2007 USA Breast, lymphoma, colorectal,
melanoma and other cancer
Logistic regression ` Mental health diagnoses, co-morbidities,
socio-demographics, use of primary
care physician, oncologist, psychiatrists,
Use of mental health
provider services
Good
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Table 1 Study Characteristics (Continued)
survivors Mean age 60 years
n = 1,111 Controls n = 4,444
psychologists, social workers and
inpatient hospitalisations (both general
and mental).
Ellison et al. [33] 2003 USA SEER database Colorectal cancer
survivors >65 years old
n = 52, 105
Kaplan-Meier survival
analysis Unconditional
regression analysis
Cox regression
Socio-demographic, hospital and
clinical characteristics, receipt of
colonoscopy, sigmoidoscopy,
endoscopy and barium enema
Differential receipt of
colonoscopy,
sigmoidoscopy,
endoscopy and barium
enema by race
Good
Gray et al. [41] 2000 Canada Breast cancer survivors n = 731
Histologically confirmed and
invasive
Stepwise logistic regression Use of specialised supportive
care services, wish to use services that
were not accessed, social and
demographic characteristics.
Use of professional
supportive care services
provided by the Ontario
health care system
Very good
Gray et al. [42] 2002 Canada Breast cancer survivors 63 %
<60 years old 23–36 months
post-diagnosis n = 731
Logistic regression Supportive care from physicians and
nurses, socio-demographics,
illness and treatment
information
Use of professional
supportive care
Good
Grunfeld et al. [16] 1999 UK Breast cancer survivors n = 148
Two district general hospitals
Two-tailed t-test and
chi-square
Record of visits, average
cost of visits, out-of patient
expenses, waiting times,
lost earnings and lost
earnings of accompanying
person
GP follow-up vs. Hospital
follow-up. Cost-effectiveness
and cost to patient,
Average
Grunfeld et al. [17] 2011 Canada Breast cancer survivors n = 408
Nine tertiary cancer centres
Two-tailed t-test Use of survivorship care plans
(vs. no survivorship care plans)
in primary care physician
led follow-up. Frequency of
visits to oncologists.
Primary care physician led
follow-up
Very good
Keating et al. [25] 2006 USA SEER-MEDICARE database Breast
cancer survivors Stage 1 or 2
Underwent surgery >65 years old
Repeated-measures
logistic regression
Mammogram receipt, visits
to primary care physician
medical oncologist, general surgeon,
radiation oncologist and
other specialists, socio-demographics
Factors related to
mammography use
Very good
Keating et al. [11] 2007 USA SEER database Breast cancer
survivors >65 years old n = 37,967
in year 1 n = 30,406 in year 2
n = 23,016 in year 3
Repeated-measures
logistic regression
Receipt of bone scans, tumour
antigen tests (TAT), Chest x-rays
and other abdominal/chest imaging,
frequency of visits to physicians
and socio-demographics
Receipt of a number of
surveillance procedures
and visits to physicians
over time
Very good
Khan et al. [38] 2010 UK GPRD database Breast cancer
survivors N = 18, 612 Colorectal
cancer survivors N= 5, 764
Prostate cancer survivors
N = 4, 868 >30 years old
5 years post-diagnosis
Controls N= 116,418
Multivariate regression Socio-demographics, use of primary
care, frequency of visits
Primary care
consultations
Very good
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Table 1 Study Characteristics (Continued)
Khan, Watson
and Rose [20]
2011 UK GPRD database Prostate cancer
survivors N = 4,868 Breast cancer
survivors N = 18,612
Colorectal cancer survivors
N = 5,764 Controls
N = 145,662
Logistic regression Co-morbidities, screening (PSA,
cervical, mammogram), receipt of
preventative procedures and socio-
demographics
Receipt of screening and
preventative care
Very good
Knopf et al. [37] 2001 USA SEER database Colorectal
cancer survivors >65 years
old n = 52, 283
Kaplan-Meier survival
analysis
Receipt of colonoscopy, sigmoidoscopy,
endoscopy and barium enema,
age, tumour stage at diagnosis
and year of diagnosis
Receipt of bowel
surveillance
procedures
Very Good
Lafata et al. [30] 2001 USA Colorectal cancer survivors
n = 251
Kaplan-Meier survival
analysis Cox proportional
hazards
Socio-demographics, receipt of
colonoscopy, CEA, barium enema,
chest x-ray, MRI’s, ultrasounds and liver
analysis
Receipt of colon
screening procedures
and other procedures
Very good
Mahboubi et al. [15] 2007 France Colorectal cancer survivors
<65 years old N= 389
Logistic regression Co-morbidities, chest radiograph,
abdominal ultrasound, colonoscopy,
CT, TAT, blood tests and reason
for testing (routine or symptomatic)
Characteristics
associated
with visits
to GPs
Very good
Mandelblatt et al. [13] 2006 USA Breast cancer survivors n = 418
Stage 1 and 2
Multivariate linear
regression
Calendar diary of health service use,
socio-demographics, cancer treatment
information, co-morbidities and
psychological status survey
Patterns and
determinants
of health
service use
Very good
Mayer et al. [35] 2007 USA NCI 2003 HINTS5n = 619
Breast cancer survivors n = 119
Prostate cancer survivors
n = 62 Colorectal cancer survivors
n = 49 Others n = 389
Logistic regression Based on the health belief
model (HBM),6 cancer communication,
cancer history, general cancer
knowledge, cancer risk and screening,
health status and demographics.
Screening
practices and
beliefs
Very good
McBean, Yu
and Virnig [39]
2008 USA SEER database: Uterine cancer
survivors >65 years old
n = 14,575 Controls n = 58,420
Multivariate logistic
regression Generalised
equation modelling
Receipt of flu vaccine, bone
densitometry, colorectal
screening and mammogram
no. of physician services and
socio-demographics
Use of preventive
services and
frequency of
physician visits
Very good
Mols, Helfenrath
and van de Poll-
Fanse [14]
2007a Netherlands Endometrial cancer Prostate
cancer Non-Hodgkin’s
lymphoma survivors
n = 1,112
Linear regression
Multivariate linear
regression
SF-36, self-reported
health service use, frequency
of visits, co-morbidities
and socio-demographics
Patterns of
physician use
Very good
Mols, Coebergh
and van de Poll-
Fanse [22]
2007b Netherlands Endometrial cancer Prostate
cancer, Hodgkin’s and
non-Hodgkin’s lymphoma
survivors n = 1,231
Chi-square and multivariate
logistic regression
Co-morbidity, socio-demographics,
use of medical specialist, general
practitioner, additional services
(physiotherapist. and psychologist)
Frequency of
physician use
Very good
Oleske et al. [47] 2004 USA Breast cancer survivors Aged
between 21–65 years
n = 123
Multivariate logistic
regression
Use and frequency of
physician and admissions,
services in past 12 months.
reasons for hospitalisations,
SRS (social responsiveness
scale) and CES-D (depression
scale)
Determination
of factors associated
with hospitalisation
Very good
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Table 1 Study Characteristics (Continued)
Peuckmann et al. [12] 2009 Denmark Breast cancer survivors n = 1,316
Controls n = 4,865
Risk ratios and multiple
logistic regression analysis
Frequency of physical visits,
socio-demographics,
physical activity and
BMI. HR-QOL (SF-36) and
chronic pain
Frequency and
determinants of health
service use
Very good
Schapira, McAuliffe
and Nattinger [32]
2000 USA SEER database Breast cancer
survivors >65 years old
n = 3,885
Logistic model Receipt of mammogram,
co-morbidity, socio-economic
status (SES) and preventive
treatment received
Receipt of Mammogram
over two year period
Good
Schootman et al. [44] 2008 USA SEER database Breast cancer
survivors >65 years old
n = 47, 643
Restricted iterative
generalised least squares
and first-order marginal
quasi-likelihood
estimation analysis
Frequency of Ambulatory-
Care-Sensitive Hospitalizations
(ACSH)7 SES, co-morbidity,
demographics, availability of
medical care, visits to primary
care physician and oncologists
Frequency of
Ambulatory-Care-
Sensitive
Hospitalizations
Very good
Simpson, Carlson
and Trew [18]
2001 USA Breast cancer survivors
Time point 1 n = 46 Time
point 4 n = 30 Controls Time
point 1 n = 43 Time point 4
n = 25
ANOVA Average cost of care, no. of
cancer centre visits and a
number of psychological
distress indicators including BDI,
POMS and Mental adjustment
to cancer scale
Billing of Health
care as a proxy to
use. Visits to
cancer centre
Correlation of
billing to distress.
Good
Snyder et al. [9] 2008a USA SEER database Colorectal
cancer survivors >65 years old
n = 1,541
Poisson regression
and logistic regression
Clinical and socio-demographic
characteristics, visits to primary
care physician, oncologist or
other physicians. Receipt of
influenza vaccine, cholesterol
screening, mammogram,
cervical screening
and bone densitometry
Frequency of
physician visits
and receipt
of preventive care
Very good
Snyder et al. [10] 2008b USA SEER database Colorectal
cancer survivors >65 years old
n = 20,068
Poisson regression
and logistic regression
analysis
Co-morbidities, socio-demographics,
visits to primary care physician,
oncologist and other physicians,
receipt of influenza vaccine,
cholesterol screening, mammogram,
and bone densitometry
Visits to physicians
and receipt of
preventive care
Good
Snyder et al. [24] 2009a USA SEER database Breast cancer
survivors >65 years old n = 23, 73
Controls n = 23, 731
Poisson regression
and logistic regression
analysis
Use of physician and
oncology services, receipt
of 5 preventive care services
and socio-demographics.
Visits to physicians
and oncologists
and preventive
medicine
Good
Snyder et al. [26] 2009b USA SEER database Breast cancer
survivors >65 years old Stages 1–3
n= 1,961 Controls n = 1,961
Poisson regression
and logistic regression
analysis
Co-morbidities, clinical
and demographic
characteristics, visits to
primary care physician,
oncologists and other
physicians
Frequency of
visits to
physicians
Good
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Table 1 Study Characteristics (Continued)
Van de Poll-
Fanse et al. [21]
2006 Netherlands Breast cancer survivors Invasive
n = 183
Logistic regression Co-morbidities, spontaneously
reported problems, use of GP, medical
specialist and physiotherapist,
health status and psychological
well-being
Use of physician
services
Good
Yu, McBean
and Virnig [40]
2007 USA SEER database Colorectal cancer
survivors >65 years old
n = 112, 737.
Logistic regression
and poisson regression
Socio-demographic
characteristics, co-morbidities,
receipt of mammogram,
visits to primary care physician,
Gynaecologists only, oncologists
and other
Receipt of mammogram
and visits to physicians
Good
1Usual source of care refers to whether an individual receives care from the same physician or different physicians; 2Medicare is a government-funded medical care plan in USA, whereby individuals aged 65 and over
that covers medical expenses such as doctor's visits, hospital stays, drugs and other treatment; 3CEA testing is used as a tumour marker for particular cancers, such as colorectal; 4HMOs provide their members with
medical services for a fixed fee; 5NCI HINTS is the Health Information National Trends Survey, which collects nationally represented information on how the American public find and use information on cancer;
6Developed by Hochbaum (1958) is an explanatory and predictive model of health behaviours and includes attitudes and beliefs of an individual; 7ACSH are hospitalizations which could have been prevented if
primary care services had been initially accessed by the individual.
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Table 2 Study results
Author Outcome Predisposing characteristics Enabling characteristics Need characteristics
Andersen and
Urban [36]
Follow-up cancer surveillance Previous diagnosis via
this method. Physician
recommendation.
70 % received mammography in first year. 72 %
received mammography in two years.
Andrykowski and
Burris [45]
Mental health service use Rural are less likely to
have mental health
services within 30 mile
radius.
18 % of non-rural and 8 % of rural CSs utilised
psychologist services.
Boehmer et al. [34] Follow-up cancer surveillance Female CSs less likely than male
CSs to receive either colonoscopy
or sigmoidoscopy within 1 and
3 years of treatment. Black CSs
more likely than white CSs to
receive follow-up screening.
A greater number of
outpatient visits.
Cooper et al. [29] Follow-up cancer surveillance Older CSs less likely than younger
CSs to receive screening within
5 years of diagnosis.
Geographical variation
in receipt.
CSs with a co-morbidity were less likely than CSs
without a co-morbidity to receive colonoscopy or
sigmoidoscopy in first year of survivorship.
Increase in receipt of surveillance procedures
over time. Over a 3 year period: 58 % of CSs
received on average 2.8 colonoscopies;
19 % received on average 2.0 colonoscopies.
Cooper and
Payes [28]
Follow-up cancer surveillance Older CSs less likely than younger
CSs to receive screening within
3 years of diagnosis. Female CSs
were more likely than male CSs
to receive screening within 3 years
of diagnosis. White CSs were more
likely than black CSs to receive
screening.
Visits to a primary care
physician.
Receipt of colonoscopy increased over time.
No difference in receipt of FOBT or colonoscopy
between CSs and controls.
Cooper, Kou and
Reynolds [31]
Follow-up cancer surveillance Older CSs less likely than younger
CSs to receive follow-up which
adheres to professional guidelines.
White CSs more likely than Black
CSs to receive follow-up which
adheres to professional guidelines.
CSs with a comorbidity were more likely than
CSs without a co-morbidity to receive CEA testing.
CSs with later stage and undifferentiated tumour
were more likely to exceed guidelines. Decrease
over time in receipt of barium enema and
sigmoidoscopy.
Doubeni et al. [27] Primary care use Follow-up
cancer surveillance
Younger CSs were more likely to
receive a mammography compared
to older CSs. White CSs were more
likely to receive a mammography
compared to black CSs.
Visits to a family physician increased from
55-71 % over a 5 year period. CSs with
co-morbidities were less likely than CSs
without co-morbidities to receive a
mammography.
Earle et al. [23] Primary care use Preventative care Older CSs were less likely to receive
preventative care compared to younger
CSs. Black CSs were less likely to receive
preventative care compared to white
CSs CSs with lower SES were less likely
to receive preventative care compared
Visits to a primary care
physician and an oncology
specialist.
52 % of CSs followed up by both an oncology
specialist and primary care physician. 41 % of
CSs followed up by primary care physician only.
4 % of CSs followed up by oncology specialist
only. CSs with a co-morbidity were more likely to
receive preventative care compared to CSs
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Table 2 Study results (Continued)
to CSs with higher SES. CSs residing in
a rural area were less likely to receive
preventative care compared to CSs
residing in an urban area.
without a co-morbidity. CSs received more
preventative care compared to controls.
Earle and Neville [19] Primary care use Preventative care Non-white CSs were less likely than
white CSs to receive preventative care.
Older CSs compared to younger CSs
were less likely to receive preventative
care.
No visits to primary care
physician or oncology
specialist led to less
preventative care receipt.
CSs compared to general population were more
likely to visit a primary care physician. 50 % of
CSs visited oncology specialist and other
physicians. 8 % of CSs visited oncology specialist
only. CSs with a co-morbidity were less likely to
receive lipid testing than CSs without a
co-morbidity. CSs were less likely than controls
to receive lipid or cholesterol testing.
Earle, Neville and
Fletcher [43]
Mental health service use Younger breast CSs (>65 years old)
were most likely to use mental health
services.
CSs compared to controls were more likely to
report anxiety and sleep disorders and have
greater use of mental health services. 18 % of
CSs made at least 2 or 3 visits to a psychologist.
Breast cancer survivors had greatest level of use.
Ellison et al. [33] Follow-up cancer surveillance White CSs were more likely to receive
post-treatment surveillance compared
to black cancer survivors.
Use of colorectal surveillance test increased
over time for colorectal CSs.
Gray et al. [41] Mental health service use Younger CSs were more likely to use
mental health services than older CSs.
CSs who were employed were more
likely to receive mental health services
than CSs who were unemployed. CSs
who were students were more likely to
receive mental health services than
CSs who were not students.
CSs who had additional health
insurance were more likely
to use mental health services
than CSs who did not have
additional insurance.
Gray et al. [42] Mental health service use Younger CSs were more likely to use
mental health services compared to
older survivors.
CSs with additional health
insurance, higher income and
higher education were more
likely to use mental health
services compared to CSs
without additional health
insurance, with lower income
and education.
Younger CSs, with additional health insurance
and a higher level of education expressed a
need for services that they were not receiving.
31 % CSs made at least one visit to a mental
health professional, 5 % to a psychologist and
4 % were to a psychiatrist. 0-11 % of CSs used
social services, dieticians, physiotherapists
and other health care providers.
Grunfeld et al. [16] Hospital care CSs led by hospital follow-up had lower health
service use compared to CSs led by primary
care physician follow-up.
Grunfeld et al. [17] Primary care use A small proportion of CSs followed
up by primary care physician made
contact with an oncologist in a
12 month period.
Keating et al. [25] Primary care use Follow-up
cancer surveillance
Younger and white CSs were more
likely to receive a mammogram than
CSs who were older and black.
Visits to oncology specialists led
to a greater likelihood in the
receipt of mammogram by CSs.
Visits to primary care physicians increased over
time, whereas visits to oncology specialists
decreased over time. A recent diagnosis, a
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Table 2 Study results (Continued)
second cancer, large tumour and no radiotherapy
receipt led to a greater likelihood of
mammography receipt.
Keating et al. [11] Primary care use Younger CSs were more likely to visit
an oncology specialist.
The role of care provided by both primary care
physicians and oncology specialists decreased
over a three year period. Annual follow-up was
provided to 51 % of breast CSs by primary care
physicians and 27 % of CSs by oncology
specialists.
Khan et al. [38] Follow-up cancer surveillance
Preventative care
Older CSs were more likely than younger
survivors to receive influenza vaccination.
A greater number of visits to a
health care provider facilitated
receipt of preventative care.
Receipt of mammography decreased over time.
CSs compared to the general population had
similar rates of cholesterol testing and blood
pressure monitoring. Colorectal CSs were more
likely to receive PSA testing. Breast CSs were less
likely than the general population to receive
preventative care with the exception of bone
densitometry.
Khan, Watson
and Rose [20]
Primary care use Visits to primary care physician increased over
time by CSs. CSs compared to the general
population were more likely to visit their primary
care physician.
Knopf et al. [37] Follow-up cancer surveillance Receipt of a number of colorectal cancer
surveillance procedures increased over time for
colorectal CSs following treatment.
Lafata et al. [30] Follow-up cancer surveillance Older CSs were less likely than younger
CSs to receive follow-up screening within
5 years of treatment with curative intent.
White CSs were more likely to receive
follow-up screening than black CSs.
Receipt of colonoscopy and CEA and metastatic
disease testing increased over time.
Mahboubi et al. [15] Primary care use Follow-up
cancer surveillance
CSs living in specific geographic areas. 21 % of all colorectal surveillance
procedures within 3 years of curative
surgery were delivered by a primary
care physician and 41 % by a
gastroenterologist or oncology
specialist.
Increased visits to primary care physicians over
time.
Mandelblatt et al. [13] Primary care use Hospital care
Follow-up cancer surveillance
White CSs were more likely to utilise
health services than black CSs.
CSs with a co-morbidity, self-reported poor
functioning and high depression scores had
greater use and cost of health services. Within
the first year of survivorship an average of 14
visits per CS was made to a medical provider.
An average of 3 visits to a physiotherapist/
occupational therapist per CS was made.
62 % of CSs received a mammography.
Mayer et al. [35] Follow-up cancer surveillance CSs had a greater absolute or comparative
risk of developing cancer compared to
the general population.
Physician recommendation increased
likelihood of screening.
Greater receipt of screening among CSs
compared to general population.
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Table 2 Study results (Continued)
McBean, Yu and
Virnig [39]
Preventative care Older and black CSs were less likely to
receive preventative care compared to
younger and white CSs.
Uterine CSs most likely to receive
mammography if seen by a
gynaecologist or an oncology specialist.
CSs most likely to receive bone
densitometry and influenza vaccination
if seen by a primary care physician.
Receipt of each test most likely if at
least 5 visits to a physician and no
overnight hospital stays.
Uterine CSs more likely to receive colorectal or
breast cancer screening than the general
population.
Mols, Helfenrath
and van de Poll-
Fanse [14]
Primary care use Hospital care CSs had similar use of primary care physician
compared to general population. 0-11 %
utilised social services, dieticians and
physiotherapists.
Mols, Coebergh
and van de Poll-
Fanse [22]
Primary care use Mental health
service use
CSs diagnosed between 10 and 15 years
previously, who were single or divorced
were less likely to utilise health services
compared to CSs diagnosed at different
time-points and CSs with partners.
Higher education enabled use of
mental health services.
CSs with a co-morbidity were twice as likely to
utilise primary care physician services than CSs
without a co-morbidity. Endometrial CSs had
greater use of health services than the general
population. 1-10 % of CSs utilised psychologist
services.
Oleske et al. [47] Hospital care 25 % of CSs had at least one overnight hospital
stay. Experiencing menopausal symptoms and
high CES-D scores led to more inpatient stays.
Peuckmann et al. [12] Primary care use Older CSs (<75 years old) were most likely
to visit their primary care physician within
3 years of treatment.
CSs had similar primary care physician use
compared to the general population. Breast CSs
had greater use of allied health professionals
than the general population.
Schapira, McAuliffe
and Nattinger [32]
Follow-up cancer surveillance CSs with a co-morbidity were less likely than CSs
without a co-morbidity to receive a
mammography. 23 % of CSs received a
macmography in the first 2 years following
treatment.
Schootman et al. [44] Hospital care Older, divorced or widowed CSs were
more likely to be an inpatient than CSs
who were younger, not divorced and not
widowed. CSs who were not black or white
were less likely to be an inpatient than CSs
who were black or white.
CSs living in an impoverished
area were more likely to have
an overnight stay in hospital
compared to CSs living in more
affluent areas. CSs who had
visited their physician at least
once were less likely to have
an overnight stay than CSs who
did not visit their physician.
13 % of CSs had at least one overnight hospital
stay. CSs with at least one co-morbidity were
more likely to have an overnight stay compared
to CSs without a co-morbidity.
Simpson, Carlson
and Trew [18]
Primary care Participation in psychotherapy
intervention led to a reduction
in health service use by CSs.
Snyder et al. [9] Primary care use Preventative
care
Younger, female colorectal CSs were more
likely to receive care form both a primary
care physician and oncology specialist
CSs who lived in an urban area
compared to CSs who lived in a
rural area were more likely to
CSs had increased visits over time to primary
care physician. CSs had decreased visits to
oncology specialists over time. Receipt of
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Table 2 Study results (Continued)
compared to older, male CSs. Older CSs less
likely to receive cholesterol testing, cervical
examination and bone densitometry than
younger CSs.
receive mammography, cervical
smear and influenza vaccination.
Most likely to receive preventative
care if followed-up by both
primary care physician and
oncology specialist. CSs living in
rural areas were less likely to receive
mammography compared to CSs
living in urban areas.
mammography and cervical screening decreased
over time. Bone densitometry remained low.
Rates of influenza vaccination fluctuated over
time. CSs with a co-morbidity were less likely to
receive cervical screening and bone densitometry,
but greater receipt of influenza vaccination,
cholesterol testing than CSs without a
co-morbidity.
Snyder et al. [10] Primary care use Preventative
care
Older CSs (>85 years old) were more likely
to receive care from a primary care physician
compared to CSs aged <75 years old. Black
CSs were more likely to receive care from
physicians other than a primary care physician.
Black CSs compared to white CSs were less
likely to receive care from a primary care
physician. Non-white CSs were less likely to
receive influenza vaccination than white CSs.
Older CSs less likely to receive cholesterol
testing and bone densitometry but were
more likely to receive influenza vaccination
than younger CSs.
Most likely to receive preventative
care if followed-up by both primary
care physician and oncology specialist.
CSs had increased visits over time to other
physicians. CSs with a co-morbidity were less
likely to receive cervical screening and bone
densitometry, but greater receipt of influenza
vaccination, cholesterol testing and
mammography than CSs without a co-morbidity.
Snyder et al. [24] Primary care use Follow-up
cancer surveillance Preventative
care
Breast CSs were most likely to receive
preventative care if visits were made
to an oncology specialist and a
primary care physician.
Majority of CSs followed up by both oncology
specialist and primary care physician over time.
Increased visits to oncology specialist over time.
Decreased visits to primary care physician over
time. Breast CSs had greater use of
mammography compared to the general
population. Breast CSs received less preventative
care than the general population. CSs more likely
to receive preventative care if general population
has a co-morbidity.
Snyder et al. [26] Primary care use
Preventative care
Increased visits to primary care physician over
time. Decreased visits to oncology specialist
over time. Breast CSs received less preventative
care than the general population.
Van de Poll-
Fanse et al. [21]
Primary care use Younger CSs were more likely to visit an
oncology specialist compared to older CSs.
Breast CSs had similar primary care physician
use as the general population.
Yu, McBean
and Virnig [40]
Follow-up cancer surveillance Older CSs were less likely to receive
mammography compared to younger CSs.
CSs with state health insurance were
less to receive a mammography
compared to CSs with alternative
health insurance. CSs living in a rural
area were less likely to receive
mammography compared to CSs
living in an urban area. Care from a
gynaecologist rather than a primary
care physician led to greater
receipt of mammography.
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colorectal CSs were consistently less likely to receive sur-
veillance procedures within 3 years of diagnosis [28], 5 years
of diagnosis and treatment [29,30], and they were also less
likely to receive follow-up surveillance in adherence to gov-
ernment follow-up guidelines [31]. At the time of the study
a number of guidelines for colorectal cancer follow-up care
had been developed but none had been widely implemen-
ted. Therefore, the authors amalgamated these guidelines
to create a minimum number of service and procedure re-
ceipt recommendations. These recommendations included:
at least two visits to a physician per year; the receipt of at
least two Carcino-Embryonic Antigen (CEA) tests within
each of the first two years of survivorship; and the receipt
of at least one colonoscopy within the first three years of
survivorship. Excess of government guidelines included re-
ceiving the minimum level of care in addition to the receipt
of at least one CT scan and/or at least one PET scan [31].
Older breast CSs were also less likely to receive mammo-
grams compared to their younger counterparts [25,27,32].
The majority of the evidence regarding ethnicity and
uptake of follow-up surveillance found that white CSs
were more likely to receive follow-up screening
[25,27,28,30,32,33] and to adhere to the guidelines speci-
fied above [31] than CSs of other ethnicities. A study
based at a ‘safety-net hospital’ which provided care to
underserved populations such as ethnic minorities found
that black colorectal CSs were more likely to receive
follow-up colonoscopies within 3-years of curative resec-
tion than CSs of other ethnicities [34]. The extent to
which gender predisposes follow-up cancer surveillance
is unclear. Within the first three years of diagnosis,
females were more likely to utilise colorectal screening
compared to male colorectal CSs, [28] but were less
likely than males to receive either colonoscopy or sig-
moidoscopy within 1 and 3 years of treatment [34].
Colorectal CSs perceived a greater absolute and com-
parative risk for developing cancer leading to greater re-
ceipt of screening compared to non-cancer controls [35].
Enabling characteristics
Factors which enabled receipt of follow-up surveillance
included visits to specific health-care providers, fre-
quency of health-care contact, area of residence, phys-
ician recommendation of test and previous cancer
diagnosis detected via screening procedure. Variations in
colorectal cancer surveillance uptake by French colorec-
tal CSs were dependent on type of physician; 21 % of all
colorectal surveillance procedures within 3 years of
curative surgery were delivered by a primary care phys-
ician and 41 % by a gastroenterologist or an oncologist
[15]. An increased number of outpatient visits led to a
greater likelihood of receiving colonoscopy or sigmoid-
oscopy within 3 years of treatment for colorectal CSs
[34]. A significant geographical variation in receipt of
surveillance procedures was also observed for colorectal
CSs [29]. An explanation for this variation given by the
authors was the influence of local practice on testing.
Moreover, a physician recommendation of follow-up
procedures increased the likelihood of procedure uptake
for breast CSs and prostate CSs [35,36]. Receiving a pre-
vious breast cancer diagnosis detected by a mammogram
was significantly and positively associated with subse-
quent receipt of mammogram in the survivorship period
[36].
Need characteristics
Co-morbid illnesses, cancer stage and treatment history
were significant need characteristics associated with re-
ceipt of follow-up surveillance. Presence of a co-morbid
illness led to a lower likelihood of receiving follow-up
surveillance. Colorectal CSs with a co-morbidity were
less likely to receive colonoscopy and sigmoidoscopy
than CSs without a co-morbidity in the first year of sur-
vivorship and were less likely to receive CEA testing to
the standard recommended by US follow-up guidelines
which included receiving at least two CEA tests per year
[29,31]. This finding is further supported by the breast
cancer survivorship literature. Breast CSs with co-
morbidities compared to CSs without co-morbidities
were less likely to receive a mammogram [25,27,32].
Colorectal CSs with later stage and an undifferentiated
cancer were more likely to exceed recommended guide-
lines which included receipt of at least one CT and/or
PET scan, in addition to minimum recommendations
[31]. Further factors associated with mammography re-
ceipt for breast CSs were a more recent diagnosis, a sec-
ondary cancer, a large tumour and no history of
adjuvant radiotherapy [11]. Comparisons of surveillance
procedure receipt between CSs and non-cancer controls
were largely consistent. Breast CSs had significantly
greater use of mammogram compared to controls when
adjustments were made for age, race and access to
health-care [26,35]. A similar result was found for PSA
testing among prostate CSs [35]. However, one study
found that having a cancer history did not lead to differ-
ential receipt of Faecal Occult Blood Test (FOBT) or
colonoscopy compared to the general population [28].
Rates of follow-up surveillance receipt varied across
studies and cancer sites, overall rates of uptake were low
to moderate. Eleven percent of colorectal CSs received
at least one surveillance procedure each year [28]. Over
a three year period, 58 % of colorectal CSs in the USA
received on average 2.8 colonoscopies, a lower percent-
age (19 %) received on average 2.0 sigmoidoscopies and
there was an observed decrease in the receipt of barium
enema and sigmoidoscopy [29,31]. In contrast to this
finding some studies reported an increase over time in
the receipt of a number of colorectal cancer surveillance
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procedures following treatment specifically colonoscopy,
CEA testing and metastatic disease testing [28-31,37].
For breast CSs the receipt of mammography decreased
over time, with the exception of one study. Sixty-two
percent of breast CSs received a mammography in both
the first and second years of survivorship whereas 23 %
of breast CSs received a mammogram in either year of
the first two years of survivorship [13,32]. A further two
studies reported a decrease over time in mammogram
receipt [27,38] whereas another study reported an in-
crease over a two year period [36]. A few studies
assessed the level of surveillance receipt in comparison
to government-recommended guidelines. The majority
of CSs did not meet recommended levels of surveillance
receipt; in one study 17 % of colorectal CSs met the
guidelines, 23 % exceeded the guidelines and 60 % failed
to meet the guidelines. Guidelines have been described
above [31]. In the first year of survivorship between 11-
59 % of breast CSs received surveillance procedures such
as a chest x-ray which were not recommended by Ameri-
can Society of Clinical Oncology (ASCO) guidelines [11].
Preventive care
Predisposing characteristics
Significant predisposing variables for receipt of prevent-
ive care included ethnicity and age. White CSs were
consistently more likely to receive preventive care than
non-white CSs. Colorectal CSs who were non-white
were less likely to receive preventive care, particularly
influenza vaccination [9,19] than white CSs. Further-
more, white breast and uterine CSs were more likely to
receive preventive care compared to black CSs [23,39].
The evidence was consistent regarding age and receipt
of preventive care, whereby older CSs were less likely to
receive preventive care (with the exception of influenza
vaccination) than their younger counterparts. Older
colorectal CSs were less likely to receive preventive care
including cholesterol testing, cervical examination, bone
densitometry and mammography, [9,10,19,40] but were
more likely to receive influenza vaccinations than
younger cancer survivors [10]. Older breast and uterine
CSs were less likely to receive preventive care compared
to younger CSs [23,39]. A UK-based study found that
colorectal, breast and prostate CSs over the age of 65
were more likely to receive influenza vaccination than
younger CSs [38].
Enabling characteristics
Enabling characteristics associated with the receipt of
preventive care included visits made to specific physi-
cians, frequency of health-care contact, area of resi-
dence, socio-economic status, overnight hospitalisations
and health insurance. Visits to more than one type of
health-care provider (i.e. primary care physician and
oncologist) were more likely to facilitate receipt of pre-
ventive care. This finding was consistent for both colo-
rectal and breast CSs respectively [9,10,23,24,26]. Visits
made by colorectal CSs to either a primary care phys-
ician or an oncologist facilitated receipt of preventive
care, but not at the same level as visits made to both
health-care providers; whereas CSs who did not visit
either health care provider received the lowest levels of
preventive care receipt [19]. Moreover, general prevent-
ive care (i.e. bone densitometry) was more likely to be
delivered by a primary care physician than any other
type of physician. Oncologists and gynaecologists were
more likely to deliver cancer-related preventive care
such as mammography to colorectal and uterine CSs re-
spectively [9,40]. Moreover, an increasing number of vis-
its to a health-care provider was the strongest predictor
for receipt of preventive care for a sample of UK CSs
[38]. A study of uterine CSs in the US quantified this
amount as 5 or more visits to a physician [39]. Living in
an urban area was significantly associated with greater
receipt of mammography, influenza vaccination and
cervical smear among colorectal CSs [9,40] and general
preventive care among breast CSs [23]. One study
reported that breast CSs who had lower socio-economic
status were less likely to receive preventive care com-
pared to breast CSs with higher socio-economic status
[23]. Receipt of preventive health services among uterine
CSs who had not been hospitalised was greater com-
pared to CSs who had been hospitalised. Furthermore,
colorectal CSs with private health insurance were more
likely to receive a mammogram compared to colorectal
CSs with government-funded health insurance [39].
Need characteristics
Colorectal CSs with a co-morbidity were less likely to re-
ceive lipid testing, cervical screening and bone densi-
tometry, but were more likely to receive influenza
vaccination, cholesterol testing and mammography com-
pared to CSs without a co-morbidity [9,10,19]. Con-
versely, breast CSs with a co-morbidity were more likely
to receive overall preventive care than CSs without a co-
morbidity [23]. Evaluation and Management meetings
refer to service contact which is not for the intention of
procedures or tests. Survivors with a co-morbidity who
attended for Evaluation and Management meetings were
more likely to receive a mammography than CSs who
did not attend for Evaluation and Management meetings
[40]. Rates of preventive care receipt were not consistent
between CSs and non-cancer controls. Breast and uter-
ine CSs were more likely than controls to receive pre-
ventive care such as colorectal cancer screening [23,39].
An UK-based study found comparative rates of choles-
terol testing and blood pressure monitoring between
CSs (including prostate and breast cancers) and the
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general population, but a 19 % increased likelihood of
PSA testing for colorectal CSs compared to the general
population [38]. Comparisons of preventive care receipt
between breast CSs and healthy controls demonstrated
that CSs were less likely to receive preventive care, par-
ticularly lipid and cholesterol testing [19,24,26]. How-
ever, they were more likely to receive bone densitometry
or general preventive care than non-cancer controls with
co-morbidities [24,38]. Colorectal CSs receipt of mam-
mography and cervical screening decreased over time,
receipt of bone densitometry remained low, whereas
rates of influenza vaccination fluctuated over time [9].
Hospital care including mental health services
Predisposing characteristics
Support was found for age, employment and student sta-
tus as predisposing characteristics associated with the
use of mental health services. Younger age (<65 year
olds vs. >65 year olds) was significantly associated with
seeking mental health or supportive care services among
breast CSs in two Canadian studies [41,42] and among
survivors of breast, lymphoma, colorectal, melanoma
and other cancers in one US study [43]. Breast CSs who
reported that they were currently employed or a student
were more likely to utilise professional supportive care
services [41].
Two US studies reported on the patterns of inpatient
hospitalisations among breast CSs. Only one of these
studies addressed the predisposing characteristics asso-
ciated with being hospitalised. Ambulatory-Care-Sensitive
Hospitalisations or preventable hospitalisations were asso-
ciated with older age, being widowed or divorced and
lower likelihood was associated with being of an ethnicity
other than white and black [44].
Enabling characteristics
Education level, household income, health insurance and
residential area were enabling factors associated with the
use of mental health services. CSs with a high level of
education were more likely to utilise mental health ser-
vices compared to CSs with a lower level of education;
this was supported by a study of endometrial, prostate
and lymphoma CSs in the Netherlands [14] and breast
CSs in Canada [41,42]. Household income which is
strongly associated with educational level was a signifi-
cant enabling characteristic for mental health service
utilisation; both Canadian studies found that higher
household income resulted in greater likelihood of using
mental health services [41,42]. Further results from these
two studies found that additional health insurance com-
pared to government-funded insurance was associated
with increased mental health service use [41,42]. One
US study addressed the impact of urban or rural resi-
dence on receipt of mental health services among breast,
colorectal and haematological CSs and found no signifi-
cant difference in service receipt despite rural CSs being
less likely to have psychiatric services within 30 miles of
their home [45].
Enabling characteristics associated with inpatient hos-
pitalisations included socio-economic status of residen-
tial area and previous visits to a physician. CSs from an
impoverished area compared to a more affluent area
were more likely to experience an Ambulatory-Care-
Sensitive Hospitalisation. However, if CSs had visited a
physician recently the risk of being hospitalised was
reduced [44].
Need characteristics
Experiencing a psychological disorder and expressing an
explicit need for mental health services was associated
with use of mental health or supportive care services.
CSs reported a greater need for and use of mental health
services compared to the general population without
cancer, due to a higher prevalence of anxiety and sleep
disorders [43]. Canadian breast CSs were asked if they
were in need of, or could not access mental health ser-
vices; breast CSs who were younger, had additional
health insurance or a high level of education, were work-
ing or studying were more likely to report an explicit
need for services [42]. Rates of mental health service
utilisation were low among CSs ranging from 1 % to18%.
Between 1 and 10 % of CSs in the Netherlands utilised
psychology services; survivors of lymphoma had the
greatest use of psychology services compared to survi-
vors of endometrial and prostate cancers [14]. There
were low utilisation rates of both psychiatric and psych-
ology services among Canadian breast CSs (4 % and 5 %
respectively) [41]. Eighteen percent of USA CSs made
on average 2 or 3 visits to a mental health professional
and breast CSs were the highest users of services [43].
Between-study variation in rates may be due to different
modes of access to services across health care systems.
Need-related factors associated with inpatient hospita-
lisations included having at least one co-morbidity, ex-
periencing menopausal symptoms and higher scores on
the Centre for Epidemiology Studies-Depression scale
(CES-D). Between 13 % and 25 % of breast CSs had at
least one overnight hospital stay [44,46].
The use of other health services such as social services
or dietetics ranged from 0-11 % of CSs [22,42]. Danish
breast CSs had greater utilisation of allied health care
professionals than the general population, [12] and US
CSs had an average number of 3 visits per survivor to a
physiotherapist or an occupational therapist [13].
Discussion
The results of this review are consonant with the Andersen
Behavioural Model of health service utilisation. Younger,
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white and employed or student CSs were more predis-
posed to access and receive health care. Individuals over
65 years old represent an at-risk group and are encouraged
by their health-care provider to receive vaccination annu-
ally [47]. According to the results of this review, older CSs
were more likely to receive influenza vaccination but not
other types of care. This discrepancy between older and
younger CSs in terms of receipt of preventive services
may be explained partly by physicians making decisions
about the utility of preventive care based on the life ex-
pectancy of CSs, [9,10,40] – this may also explain the
increased risk regarding inpatient hospitalisations among
elderly CSs. The role of incentive payments to primary
care physicians may play a part in the differential pat-
terns of preventive services utilisation. Ethnicity was
examined within US studies only and various explanations
relating to economic differences, differences in health-
seeking behaviours, preferences for treatment or percep-
tions of post-treatment cancer surveillance may account
for reported ethnic disparities [19,30,33].
Visits to primary care physicians appeared to enable
the implementation of care recommendations for CSs.
Other facilitating factors which were more pertinent in
non-nationalized or universal health-care systems were
additional health insurance, a higher education, income
and living in an urban, affluent area. Many samples
included CSs who had insurance (e.g. Medicare) and this
factor may be related to a sense of self-efficacy in terms
of seeking information and negotiating the health-care
system [42]. Cancer survivors had greater or at least
similar frequency of contact with primary care physi-
cians compared to the general population without can-
cer. Many cancer survivors may experience long-term
health problems or further ill-health following treatment
which require further care or specialist care. In many
health-care systems a primary care physician may act as a
gatekeeper for access to specialist services thus accounting
for greater frequency of visits among the cancer survivor
population.
Needs for care were also related to co-morbidity, later
stage or undifferentiated tumour and menopausal or de-
pressive symptoms. Younger, employed or student CSs
expressed a need for mental health services. Overall, as
CSs survived longer post-diagnosis they used less
cancer-oriented care, with the exception of screening.
Although the review amalgamated literature regarding
core health services, it excluded some health services
such as complementary and alternative medicine due to
resource restraints (and their perceived non-mainstream
position). Services like complementary and alternative
medicine are becoming increasingly important for CSs
and require research attention. Limitations of the review
include uncertainty about generalisability of findings.
There is a need to give consideration to the merits of
conducting comparative health care system research (in-
cluding health service research in non-USA countries),
particularly given the differing role of the oncologist be-
tween health-care systems and the role of insurance in
obtaining access to care in USA studies. Fifteen studies
comprised a secondary analysis of the SEER-Medicare
database which included individuals over the age of
65 years and excluded individuals covered by other in-
surance plans or no insurance plan. Moreover, indivi-
duals were limited by their insurance plan regarding
access to physicians and entitlement to receive particular
procedures. For example, there are additional charges
for receipt of procedures such as colonoscopy [33]. A
further issue for the review was the lack of generalisation
of results to US cancer survivors without medical insur-
ance and thus a primary care physician may not be the
first point of contact for care for some individuals. The
SEER-Medicare database also did not provide informa-
tion regarding reasons for use of services (i.e. cancer-
related follow-up or for another condition). None of the
papers reported the reasons for health service contact
and whilst CSs appeared to be using relevant health ser-
vices, this did not equate to follow-up care. It may not
have been appropriate to compare utilisation rates be-
tween CSs and ‘healthy’ individuals from the general
population as they may also have chronic illnesses; this
is an inherent limitation within the included primary
studies. Unfortunately, none of the included studies
examined the nature and extent of the coordination of
different services provided for CSs and this needs to be
empirically tested.
The Andersen Behavioural Model of health service
utilisation was used as the structural framework to or-
ganise the review. Although it is limited in its scope
regarding potentially important behavioural variables, it
does take into account the health beliefs of an individual.
Health beliefs were not extensively addressed by the
studies in the review. Indeed, only one study looked at
the perception of risk and only in respect of cancer re-
currence. There is a need to give empirical attention to
the role of research evidence-based behavioural and
‘cognitive-behavioural’ constructs in order to improve
our understanding preventive procedure receipt and
adoption of health promoting behaviours by cancer sur-
vivors [48]. Future research efforts to understand health
service use by cancer survivors should consider supple-
menting or expanding the Andersen Behavioural Model to
include behavioural and cognitive components (e.g. sub-
jective norms) from models such as the Theory of Planned
Behaviour [49].
Conclusions
The emergence and evaluation of practice guidelines
over time may impact on health service utilisation.
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Although plans are currently underway neither the USA
nor the UK have well-established guidelines which in-
dicate appropriate contact use or receipt of health ser-
vices, [50,51]. Currently, it is not clear who should
co-ordinate care plans and what they should entail [52].
Overall, personalised care plans and an active role
played by physicians were significant enablers in terms
of helping match services to the needs of CSs and fa-
cilitating co-ordinated care – at least for particular
groups of survivors.
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